Advocacy groups are urging regulators to launch a bold anticompetition probe into Big Pharma’s moves after Brexit, accusing the industry of manipulating the market and driving prices sky-high. This call highlights growing concerns over pharmaceutical practices in the evolving post-Brexit landscape
As conversations heat up, the U.S. and U.K. are moving closer to sealing a robust trade deal. Central to these discussions are tariffs, digital trade, and agricultural standards—critical elements that both nations are eager to enhance in order to fortify their economic partnership in the wake of Brexit.
UK Finance Minister has emphasized the necessity of “give and take” in ongoing negotiations to prevent the imposition of tariffs by the US. This statement reflects concerns over potential trade barriers that could impact UK businesses amid turbulent economic conditions.
